KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for CareDx (CDNA) over the last 11 years, with Q3 2025 value amounting to $5.0 million.

  • CareDx's Treasury Shares rose 890900.9% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 890900.9%. This contributed to the annual value of $4.8 million for FY2024, which is 6454.89% up from last year.
  • Latest data reveals that CareDx reported Treasury Shares of $5.0 million as of Q3 2025, which was up 890900.9% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Treasury Shares ranged from a high of $5.1 million in Q1 2025 and a low of $50051.0 during Q4 2022
  • Over the past 5 years, CareDx's median Treasury Shares value was $1.9 million (recorded in 2021), while the average stood at $2.0 million.
  • In the last 5 years, CareDx's Treasury Shares tumbled by 9755.57% in 2022 and then surged by 890900.9% in 2025.
  • Over the past 5 years, CareDx's Treasury Shares (Quarter) stood at $2.0 million in 2021, then plummeted by 97.56% to $50051.0 in 2022, then surged by 5780.0% to $2.9 million in 2023, then surged by 64.55% to $4.8 million in 2024, then rose by 3.25% to $5.0 million in 2025.
  • Its Treasury Shares stands at $5.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $5.1 million for Q1 2025.